Consensus Statements

Filter By:

Article Type
  • In this Consensus Statement, the authors delineate the thrombotic signature of COVID-19 and present the latest biomarkers and platforms to assess thrombotic risk in these patients. Consensus recommendations are made about the clinical use of these biomarkers to inform prognosis, assess disease acuity, and predict thrombosis and in-hospital mortality.

    • Diana A. Gorog
    • Robert F. Storey
    • Richard C. Becker
    Consensus Statement
  • Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. In this Consensus Statement, the authors summarize the use of SPECT, PET, MRI, echocardiography, CT and invasive coronary flow and pressure measurement, and describe the relative strengths and weaknesses of each modality.

    • Marc Dewey
    • Maria Siebes
    • Laura Schreiber
    Consensus Statement Open Access
  • In this Consensus Statement, Garg and colleagues describe the current evidence on the use of cardiovascular magnetic resonance imaging for the assessment of mitral regurgitation, highlight its current clinical utility, and recommend a standardized imaging protocol and report.

    • Pankaj Garg
    • Andrew J. Swift
    • Saul G. Myerson
    Consensus Statement Open Access
  • Patients with diabetes mellitus have a prothrombotic status that increases the risk of cardiovascular events and worsens prognosis after these events. In this Consensus Statement, the Working Group on Thrombosis of the Italian Society of Cardiology proposes antithrombotic strategies for patients with diabetes in various cardiovascular settings.

    • Giuseppe Patti
    • Ilaria Cavallari
    • Raffaele De Caterina
    Consensus Statement Open Access
  • A range of drugs is available for symptomatic angina, but the optimal choice or combination of therapies is often uncertain, and contemporary guidelines do not necessarily provide definite recommendations. In this Consensus Statement, Ferrari and colleagues propose an individualized approach to angina treatment, which takes into consideration the patient, their comorbidities, and the underlying mechanism of disease.

    • Roberto Ferrari
    • Paolo G. Camici
    • José L. Lopez-Sendon
    Consensus Statement Open Access
  • The successful management of patients with acute heart failure (AHF) involves early diagnosis, rapid identification of underlying causes, and immediate implementation of effective therapies. In this Consensus Statement, the AHF Study Group of the ESC Acute Cardiovascular Care Association reviews the roles of echocardiography and lung ultrasonography in the assessment and management of patients with AHF.

    • Susanna Price
    • Elke Platz
    • Christian Mueller
    Consensus Statement Open Access
  • The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the mechanisms of mitochondrial dysfunction in heart failure are presented, along with an overview of emerging treatments with the potential to improve the function of the failing heart by targeting mitochondria.

    • David A. Brown
    • Justin B. Perry
    • Mihai Gheorghiade
    Consensus Statement Open Access
  • To bridge the current gap between the known mechanisms of atrial fibrillation (AF) and the clinical management of patients with this arrhythmia, Fabritz and colleagues propose a roadmap to develop a set of clinical markers that reflect the major causes of AF in patients. A new, mechanism-based classification of AF can provide the basis for personalized prevention and management.

    • Larissa Fabritz
    • Eduard Guasch
    • Paulus Kirchhof
    Consensus Statement Open Access
  • East Asian patients are known to have differing risks of thrombophilia and bleeding compared with white patients, but few have been included in phase III trials of P2Y12inhibitors. Therefore, the World Heart Federation has produced this evidence-based review and expert consensus statement to determine the antiplatelet treatment strategies that are most appropriate for East Asian patients with acute coronary syndrome or undergoing percutaneous coronary intervention.

    • Glenn N. Levine
    • Young-Hoon Jeong
    • Sidney C. Smith Jr
    Consensus Statement